Trials / Unknown
UnknownNCT02647164
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (estimated)
- Sponsor
- GenoSaber · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the value of circulating tumor cells (CTC)for non-small cell lung cancer in the postoperative recurrence monitoring by comparing the CTCs, CT and tumor markers at different time points.The time of CTC and carcinoembryonic antigen(CEA) detection is baseline, 2\~7 days, 3 months, 6 months, 12 months, 24 months, 36 months after the surgery. And the time of CT detection is 6 months, 12 months, 24 months, 36 months after the surgery.
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-09-01
- First posted
- 2016-01-06
- Last updated
- 2016-01-06
Source: ClinicalTrials.gov record NCT02647164. Inclusion in this directory is not an endorsement.